99071-94-0

Basic information

• Product Name: 4(3H)-Quinazolinone, 8-hydroxy-2,3-dimethyl-
• Synonyms: 4(3H)-Quinazolinone, 8-hydroxy-2,3-dimethyl-
• CAS NO: 99071-94-0
• Molecular Formula: C10H10N2O2
• Molecular Weight: 0
• Mol File: 99071-94-0.mol

Chemical Properties

• Appearance: /
• CAS DataBase Reference: 4(3H)-Quinazolinone, 8-hydroxy-2,3-dimethyl-(CAS DataBase Reference)
• NIST Chemistry Reference: 4(3H)-Quinazolinone, 8-hydroxy-2,3-dimethyl-(99071-94-0)
• EPA Substance Registry System: 4(3H)-Quinazolinone, 8-hydroxy-2,3-dimethyl-(99071-94-0)

Safety Data

• Hazardous Substances Data: 99071-94-0(Hazardous Substances Data)

Upstream product

• 172462-98-5 2-N-Acetylamino-3-methoxybenzamide 
• 106782-78-9 3-methoxy-2-aminobenzamide 
• 90915-45-0 8-methoxy-2-methyl-4-oxo-3,4-dihydroquinazoline 
• 104296-30-2 2,3-dimethyl-8-methoxyquinazolin-4-one 
• 90915-46-1 8-methoxy-3-methyl-quinazolin-4(3H)-one 

Downstream Products

• 101444-63-7 8-hydroxy-3-methyl-2-trans-styryl-3H-quinazolin-4-one 
• 101731-85-5 8-hydroxy-2-(4-methoxy-trans-styryl)-3-methyl-3H-quinazolin-4-one 

Relevant articles and documents

Quinazolinone compounds

Phosphate derivatives are disclosed of quinazolinone compounds having structural formula (I) or a pharmaceutically acceptable salt thereof, wherein X' represent hydroxyl, alkyl, alkoxy, or O-Z where Z is a phosphate or phosphate derivative; Y' represents

Resistance-modifying agents. 5.1 Synthesis and biological properties of quinazolinone inhibitors of the DNA repair enzyme poly(ADP-ribose) polymerase (PARP)

Clinical studies concerning the role of poly(ADP-ribose) polymerase (PARP) in the repair of drug- and radiation-induced DNA damage have been impeded by the poor solubility, lack of potency, and limited specificity of currently available inhibitors. A seri

Quinazolones: Part XI - Effect of Substituents on Claisen Rearrangement of Allyloxyquinazolones

The Claisen rearrangement of 7-allyloxy-8-methoxy-2-methyl-3-phenylquinazolin-4(3H)-one (I) gives the unusual products 6-allyl-2-ethyl-7,8-dihydroxy-3-phenylquinazolin-4(3H)-one and 7-ethyl-9-hydroxy-2-methyl-6-phenylfuroquinazolin-5(6H)-one (VIb) instead of the expected 6-allyl-7-hydroxy-8-methoxy-2-methyl-3-phenylquinazolin-4(3H)-one (II).